Parallax Volatility Advisers’s iShares Biotechnology ETF IBB Stock Holding History

Parallax Volatility Advisers’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-58,500	Closed	-$7.4M	–	1706
2025 Q2	$7.4M	Buy	+58,500	New	+$7.18M	0.02%	519
2025 Q1	–	Sell	-93,700	Closed	-$12.4M	–	1811
2024 Q4	$12.4M	Buy	93,700 +14,000	+18%	+$1.97M	0.02%	499
2024 Q3	$11.6M	Buy	79,700 +46,800	+142%	+$6.77M	0.02%	494
2024 Q2	$4.52M	Buy	+32,900	New	+$4.39M	0.01%	752
2024 Q1	–	Sell	-369,100	Closed	-$50.1M	–	2067
2023 Q4	$50.1M	Buy	+369,100	New	+$45M	0.1%	179
2023 Q2	–	Sell	-400	Closed	-$51.7K	–	2632
2023 Q1	$51.7K	Sell	400 -65,200	-99%	-$8.53M	﹤0.01%	2213
2022 Q4	$8.61M	Sell	65,600 -11,000	-14%	-$1.42M	0.01%	825
2022 Q3	$8.96M	Sell	76,600 -100,000	-57%	-$12.4M	0.01%	801
2022 Q2	$20.8M	Buy	+176,600	New	+$21M	0.02%	473
2021 Q4	–	Sell	-400	Closed	-$65K	–	2087
2021 Q3	$65K	Hold	400	–	–	﹤0.01%	1811
2021 Q2	$65K	Buy	+400	New	+$61.6K	﹤0.01%	1386
2021 Q1	–	Sell	-369,200	Closed	-$55.9M	–	1564
2020 Q4	$55.9M	Buy	369,200 +11,900	+3%	+$1.7M	0.06%	280
2020 Q3	$48.4M	Buy	357,300 +277,600	+348%	+$37.7M	0.04%	404
2020 Q2	$10.9M	Buy	79,700 +17,700	+29%	+$2.26M	0.01%	741
2020 Q1	$6.68M	Sell	62,000 -700	-1%	-$80.6K	0.01%	754
2019 Q4	$7.56M	Buy	62,700 +19,400	+45%	+$2.16M	0.01%	753
2019 Q3	$4.31M	Sell	43,300 -10,700	-20%	-$1.12M	﹤0.01%	868
2019 Q2	$5.9M	Sell	54,000 -78,400	-59%	-$8.34M	0.01%	671
2019 Q1	$14.8M	Buy	132,400 +82,100	+163%	+$9M	0.02%	373
2018 Q4	$4.86M	Sell	50,300 -19,400	-28%	-$2.06M	0.01%	718
2018 Q3	$8.49M	Buy	+69,700	New	+$8.21M	0.01%	528
2018 Q2	–	Sell	-85,500	Closed	-$9.13M	–	2641
2018 Q1	$9.13M	Sell	85,500 -203,200	-70%	-$22.5M	0.01%	407
2017 Q4	$30.8M	Buy	+288,700	New	+$30.9M	0.04%	196
2017 Q1	–	Sell	-52,500	Closed	-$4.64M	–	4030
2016 Q4	$4.64M	Hold	52,500	–	–	0.01%	665
2016 Q3	$5.07M	Sell	52,500 -1,200,000	-96%	-$114M	0.01%	669
2016 Q2	$107M	Buy	1,252,500 +1,207,500	+2,683%	+$108M	0.21%	61
2016 Q1	$3.91M	Sell	45,000 -285,000	-86%	-$25.5M	0.01%	652
2015 Q4	$37.2M	Buy	330,000 +36,000	+12%	+$3.91M	0.08%	167
2015 Q3	$29.7M	Buy	294,000 +276,000	+1,533%	+$33.1M	0.07%	200
2015 Q2	$2.21M	Sell	18,000 -207,000	-92%	-$24.8M	﹤0.01%	1029
2015 Q1	$25.8M	Buy	+225,000	New	+$24.8M	0.06%	253
2014 Q3	–	Sell	-60,000	Closed	-$5.14M	–	4276
2014 Q2	$5.14M	Buy	+60,000	New	+$4.73M	0.02%	471

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Parallax Volatility Advisers's IBB Position: Q1 2026 in Review

Parallax Volatility Advisers sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 13,526 shares — an estimated $2.28M sold.

Parallax Volatility Advisers first reported a position in IBB in Q2 2014 and held it in 43 quarters. The position peaked at $29.4M in Q4 2020. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Parallax Volatility Advisers reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
Parallax Volatility Advisers sold 13,526 iShares Biotechnology ETF shares in Q1 2026, an estimated $2.28M.
Parallax Volatility Advisers first reported a position in iShares Biotechnology ETF in Q2 2014 and held it in 43 quarters.
Parallax Volatility Advisers's iShares Biotechnology ETF position peaked at $29.4M in Q4 2020.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.